Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALX1 in Adults With Bronchiectasis
NCT07731919Phase 2Not yet recruiting
- Sponsor
- Vast Therapeutics
- Start
- Sep 2026
- Primary completion
- Mar 2027
01
Overview
A Phase 2 trial of ALX1 in bronchiectasis, sponsored by Vast Therapeutics. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ALX1
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT07731919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07731919.